Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Hormone treatment of gender identity disorder in a cohort of children and adolescents. Comment.

Conway AJ, Hamblin JC, Handelsman DJ.

Med J Aust. 2012 Sep 3;197(5):273; author reply 274. No abstract available.

PMID:
22938117
2.

Hormone treatment of gender identity disorder in a cohort of children and adolescents. Comment.

Hyde Z.

Med J Aust. 2012 Sep 3;197(5):273-4; author reply 274. No abstract available.

PMID:
22938118
3.

Hormone treatment of gender identity disorder in a cohort of children and adolescents.

Hewitt JK, Paul C, Kasiannan P, Grover SR, Newman LK, Warne GL.

Med J Aust. 2012 May 21;196(9):578-81.

PMID:
22621149
4.

Gender assignment and hormonal treatment for disorders of sexual differentiation.

Sharma S, Gupta DK.

Pediatr Surg Int. 2008 Oct;24(10):1131-5. doi: 10.1007/s00383-008-2232-7.

PMID:
18704450
5.

Hormonal management of the female-to-male transgender patient.

Steinle K.

J Midwifery Womens Health. 2011 May-Jun;56(3):293-302. doi: 10.1111/j.1542-2011.2011.00037.x. Review.

PMID:
21535376
6.

Menstruation and mental health: what's the chance of talking about that?

Barrowman D.

Menopause Int. 2012 Jun;18(2):87-9. doi: 10.1258/mi.2012.012011. No abstract available.

PMID:
22611229
7.

Management of metastatic breast cancer.

Peters W.

Adv Intern Med. 1995;40:341-64. Review. No abstract available.

PMID:
7747652
8.

SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.

Godano A, Maggi M, Jannini E, Meriggiola MC, Ghigo E, Todarello O, Lenzi A, Manieri C.

J Endocrinol Invest. 2009 Nov;32(10):857-64. No abstract available.

PMID:
20065624
9.

Puberty suppression in gender identity disorder: the Amsterdam experience.

Kreukels BP, Cohen-Kettenis PT.

Nat Rev Endocrinol. 2011 May 17;7(8):466-72. doi: 10.1038/nrendo.2011.78. Review.

PMID:
21587245
10.

Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals.

Zubiaurre-Elorza L, Junque C, Gómez-Gil E, Guillamon A.

J Sex Med. 2014 May;11(5):1248-61. doi: 10.1111/jsm.12491.

PMID:
24617977
11.

Principles of endocrine manipulation in the treatment of prostatic cancer.

Neumann F.

Prog Clin Biol Res. 1985;185A:73-98. No abstract available.

PMID:
3898136
12.

Ureteral endometriosis: diagnosis and management.

Asimakopoulos G.

Rev Med Chir Soc Med Nat Iasi. 2006 Jul-Sep;110(3):575-81. Review.

PMID:
17571548
13.

Hormone therapy in cancer.

Kennedy BJ.

Geriatrics. 1970 Oct;25(10):106-12. No abstract available.

PMID:
4096937
14.

Effects of testosterone and estrogens on deltoid and trochanter adipocytes in two cases of transsexualism.

Vague J, Meignen JM, Negrin JF.

Horm Metab Res. 1984 Jul;16(7):380-1. No abstract available.

PMID:
6489925
15.
16.

Gender identity disorder.

De Gascun C, Kelly J, Salter N, Lucey J, O'Shea D.

Ir Med J. 2006 May;99(5):146-8.

PMID:
16892921
17.

Cross-sex hormone treatment does not change sex-sensitive cognitive performance in gender identity disorder patients.

Haraldsen IR, Egeland T, Haug E, Finset A, Opjordsmoen S.

Psychiatry Res. 2005 Dec 15;137(3):161-74.

PMID:
16297984
18.

Guidelines for pubertal suspension and gender reassignment for transgender adolescents.

Hembree WC.

Child Adolesc Psychiatr Clin N Am. 2011 Oct;20(4):725-32. doi: 10.1016/j.chc.2011.08.004.

PMID:
22051008
19.

Hypopituitarism.

Rogol AD.

Curr Ther Endocrinol Metab. 1994;5:26-9. No abstract available.

PMID:
7704728
20.

Sex steroids and breast cancer prevention.

Spicer DV, Pike MC.

J Natl Cancer Inst Monogr. 1994;(16):139-47. Review.

PMID:
7999456
Items per page

Supplemental Content

Support Center